
    
      Because of the results of our former trial (ALFA-9802) [Thomas, 2005], chemotherapy will be
      combined in each arm with G-CSF (Granulocyte Colony-Stimulating Factor) given during each
      sequence of chemotherapy in order to increase the blast priming.
    
  